Nasdaq
SLN
Silence Therapeutics Plc
- Health Care
- United Kingdom
- 1 day
- +4.3%
- 1 month
- +15.5%
- 1 year
- +120%
$11.72 · Mkt cap $548M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Silence Therapeutics Plc
$11.72 · Mkt cap $548M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Silence Therapeutics Plc trades under the ticker SLN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $548M. The last closing price was $11.72, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +120%, and +15.5% over the past month. Returns are price returns and exclude dividends.
This page exists because SLN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.